Given these intriguing findings, the role of EGFR and downstream signaling pathways, such as PI3K/Akt and MAPK/Erk, in BPAF-mediated cellular responses in ER+ breast cancer cell models needs to be further examined. This evidence concerns the gene EGFR and breast cancer.